Compare Stocks: MBAI, TELA, ARAY, and QTEX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARAY Accuray	$0.27 +0.3%	$0.27	$0.22 ▼ $2.10	$31.77M	1.39	654,061 shs	280,901 shs
MBAI Check-Cap	$6.50	$7.82	$4.41 ▼ $27.44	$8.94M	0.67	28,417 shs	21,150 shs
QTEX Inspira Technologies OXY B.H.N.	$0.83 +1.8%	$1.11	$0.28 ▼ $3.85	$29.42M	4.24	2.96 million shs	1.52 million shs
TELA TELA Bio	$0.82 +5.2%	$0.74	$0.50 ▼ $1.73	$36.88M	1.36	309,566 shs	115,564 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARAY Accuray	+0.30%	-2.59%	-2.73%	-21.97%	-81.73%
MBAI Check-Cap	0.00%	-1.22%	-28.57%	-32.71%	+649,999,900.00%
QTEX Inspira Technologies OXY B.H.N.	+1.85%	-0.06%	-22.82%	-41.30%	+83,349,900.00%
TELA TELA Bio	+5.19%	+17.36%	-10.22%	-6.66%	-50.21%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARAY Accuray	$0.27 +0.3%	$0.27	$0.22 ▼ $2.10	$31.77M	1.39	654,061 shs	280,901 shs
MBAI Check-Cap	$6.50	$7.82	$4.41 ▼ $27.44	$8.94M	0.67	28,417 shs	21,150 shs
QTEX Inspira Technologies OXY B.H.N.	$0.83 +1.8%	$1.11	$0.28 ▼ $3.85	$29.42M	4.24	2.96 million shs	1.52 million shs
TELA TELA Bio	$0.82 +5.2%	$0.74	$0.50 ▼ $1.73	$36.88M	1.36	309,566 shs	115,564 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARAY Accuray	+0.30%	-2.59%	-2.73%	-21.97%	-81.73%
MBAI Check-Cap	0.00%	-1.22%	-28.57%	-32.71%	+649,999,900.00%
QTEX Inspira Technologies OXY B.H.N.	+1.85%	-0.06%	-22.82%	-41.30%	+83,349,900.00%
TELA TELA Bio	+5.19%	+17.36%	-10.22%	-6.66%	-50.21%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARAY Accuray	1.67	Reduce	$2.00	649.63% Upside
MBAI Check-Cap	1.00	Sell	N/A	N/A
QTEX Inspira Technologies OXY B.H.N.	1.00	Sell	N/A	N/A
TELA TELA Bio	2.40	Hold	$2.20	167.80% Upside

Current Analyst Ratings Breakdown

Latest MBAI, TELA, ARAY, and QTEX Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/1/2026	ARAY Accuray	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/24/2026	QTEX Inspira Technologies OXY B.H.N.	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
8/4/2026	ARAY Accuray	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/21/2026	MBAI Check-Cap	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	TELA TELA Bio	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/8/2026	ARAY Accuray	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral

(Data available from 9/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARAY Accuray	$401.95M	0.08	N/A	N/A	$0.35 per share	0.76
MBAI Check-Cap	N/A	N/A	$3.96 per share	1.64	$3.30 per share	N/A
QTEX Inspira Technologies OXY B.H.N.	$290K	103.33	N/A	N/A	$0.06 per share	13.89
TELA TELA Bio	$79.91M	0.46	N/A	N/A	($0.35) per share	-2.35

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARAY Accuray	-$49.19M	-$0.40	N/A	N/A	N/A	-12.24%	-97.85%	-10.82%	11/4/2026 (Estimated)
MBAI Check-Cap	$4.14M	-$14.07	N/A	N/A	N/A	N/A	N/A	N/A	N/A
QTEX Inspira Technologies OXY B.H.N.	-$13.22M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	-$38.83M	-$0.77	N/A	N/A	N/A	-51.53%	-1,320.81%	-59.39%	11/12/2026 (Estimated)

Latest MBAI, TELA, ARAY, and QTEX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/19/2026	Q4 2026	ARAY Accuray	-$0.03	-$0.02	+$0.01	-$0.02	$105.30 million	$100.92 million
8/10/2026	Q2 2026	TELA TELA Bio	-$0.1738	-$0.20	-$0.0262	-$0.20	$20.01 million	$19.29 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARAY Accuray	N/A	N/A	N/A	N/A	N/A
MBAI Check-Cap	N/A	N/A	N/A	N/A	N/A
QTEX Inspira Technologies OXY B.H.N.	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARAY Accuray	3.51	1.50	0.74
MBAI Check-Cap	N/A	0.05	0.05
QTEX Inspira Technologies OXY B.H.N.	0.08	1.56	1.30
TELA TELA Bio	8.82	2.99	2.38

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ARAY Accuray	64.08%
MBAI Check-Cap	1.07%
QTEX Inspira Technologies OXY B.H.N.	12.72%
TELA TELA Bio	94.35%

Insider Ownership

Company	Insider Ownership
ARAY Accuray	2.40%
MBAI Check-Cap	0.48%
QTEX Inspira Technologies OXY B.H.N.	29.40%
TELA TELA Bio	5.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ARAY Accuray	1,040	119.44 million	116.57 million	Optionable
MBAI Check-Cap	80	1.38 million	1.37 million	N/A
QTEX Inspira Technologies OXY B.H.N.	20	35.95 million	25.38 million	N/A
TELA TELA Bio	120	44.90 million	42.61 million	Optionable

MBAI, TELA, ARAY, and QTEX Headlines

Recent News About These Companies

TELA Bio chief operating officer and chief financial officer resigns

September 2 at 6:36 PM | pennbizreport.comP

Tela Bio cuts 41 jobs in Malvern as new CEO launches $17M cost-reduction plan

September 2 at 6:36 PM | msn.com

Malvern medical-tech company is slashing jobs as part of cost-cutting campaign

September 1, 2026 | msn.com

Malvern firm cutting 20% of workforce as new CEO launches cost cuts

August 31, 2026 | bizjournals.com

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

August 31, 2026 | globenewswire.com

TELA Bio (TELA) Q2 2026 Earnings Call Transcript

August 19, 2026 | finance.yahoo.com

Heather Getz Acquires 15,000 Shares of TELA Bio (NASDAQ:TELA) Stock

August 18, 2026 | insidertrades.com

Tela Bio outlines 9- to 12-month sales ramp while withdrawing full-year revenue guidance

August 12, 2026 | seekingalpha.com

TELA Bio, Inc. (TELA) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

August 10, 2026 | zacks.com

TELA Bio Reports Second Quarter 2026 Financial Results

August 10, 2026 | markets.businessinsider.com

Tela Bio names new CEO as Malvern medtech company eyes next growth phase

August 5, 2026 | msn.com

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 5, 2026 | globenewswire.com

Tela Bio names new CEO as co-founder exits after 14 years

August 4, 2026 | bizjournals.com

TELA Bio Appoints Heather Getz as Chief Executive Officer and Director

August 4, 2026 | quiverquant.comQ

TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director

August 4, 2026 | globenewswire.com

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

July 29, 2026 | globenewswire.com

TELA Bio to Announce Second Quarter 2026 Financial Results

July 20, 2026 | globenewswire.com

A perfect match

July 16, 2026 | bbc.comB

TELA Bio Healthcare Story Faces New Market Scrutiny

May 15, 2026 | kalkinemedia.comK

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBAI, TELA, ARAY, and QTEX Company Descriptions

Accuray NASDAQ:ARAY

$0.27 +0.00 (+0.30%)

As of 09/4/2026 04:00 PM Eastern

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Check-Cap NASDAQ:MBAI

$6.50 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

$0.83 +0.02 (+1.85%)

As of 09/4/2026 04:00 PM Eastern

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.

TELA Bio NASDAQ:TELA

$0.82 +0.04 (+5.19%)

As of 09/4/2026 04:00 PM Eastern

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MBAI, TELA, ARAY, and QTEX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MBAI, TELA, ARAY, and QTEX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MBAI, TELA, ARAY, and QTEX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBAI, TELA, ARAY, and QTEX Company Descriptions

Accuray NASDAQ:ARAY

Check-Cap NASDAQ:MBAI

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

TELA Bio NASDAQ:TELA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MBAI, TELA, ARAY, and QTEX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MBAI, TELA, ARAY, and QTEX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MBAI, TELA, ARAY, and QTEX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBAI, TELA, ARAY, and QTEX Company Descriptions

Accuray NASDAQ:ARAY

Check-Cap NASDAQ:MBAI

Inspira Technologies OXY B.H.N. NASDAQ:QTEX

TELA Bio NASDAQ:TELA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools